Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OncoTherapy ScienceTSE:4564 -4.76%50 Days Inventory is 35.93 as of Mar. 2026, which is 7% below its 10-year median of 38.49. GuruFocus rates TSE:4564 with a GF Score™ of 50/100 and a GF Value™ of 円16.92 (Modestly Overvalued). The stock has 1 warning sign investors should review. Among 638 Biotechnology companies, OncoTherapy Science ranks better than 90.13% on this metric.
The historical rank and industry rank for OncoTherapy Science's Days Inventory or its related term are showing as below:
TSE:4564'
s Days Inventory Range Over the Past 10 Years
Min: 25.04 Med: 38.49 Max: 55.2
Current: 35.7
During the past 13 years, OncoTherapy Science's highest Days Inventory was 55.20. The lowest was 25.04. And the median was 38.49.
TSE:4564's Days Inventory is ranked better than 90.13% of 638
companies
in the Biotechnology industry
Industry Median: 183.195
vs TSE:4564: 35.70
OncoTherapy Science's Days Inventory
declined
from Mar. 2025 (51.64) to Mar. 2026 (35.93).
Inventory Turnover measures how fast the company turns over its inventory within a year.
OncoTherapy Science's Inventory Turnover for the
six
months ended in Mar. 2026 was 5.08.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
OncoTherapy Science's Inventory-to-Revenue for the
six
months ended in Mar. 2026 was 0.20.
OncoTherapy Science (TSE:4564) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
OncoTherapy Science's Inventory Turnover for the
six
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
OncoTherapy Science's Inventory to Revenue for the
six
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
OncoTherapy Science Days Inventory Related Terms
OncoTherapy Science Days Inventory Historical Data
* Premium members only.
The historical data trend for OncoTherapy Science's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4564 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, OncoTherapy Science's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OncoTherapy Science Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, OncoTherapy Science's Days Inventory distribution charts can be found below:
* The bar in red indicates where OncoTherapy Science's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OncoTherapy Science (TSE:4564) has a Days Inventory of 35.93 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on OncoTherapy Science and its competitors. This is near median its historical median of 38.49. Over the past decade, OncoTherapy Science's Days Inventory has ranged from 25.04 to 55.20. According to the industry distribution chart, OncoTherapy Science ranks #63 out of 638 companies in the Biotechnology industry, placing it in the top 9.9%.
Is OncoTherapy Science's Days Inventory too high?
OncoTherapy Science's current Days Inventory of 35.93 is near median its 10-year median of 38.49. Over the past 10 years, this metric has ranged from a low of 25.04 to a high of 55.20. The Biotechnology industry median Days Inventory is 183.20. OncoTherapy Science's value of 35.93 is 80.4% below this industry median. Based on the distribution chart, OncoTherapy Science ranks #63 out of 638 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, OncoTherapy Science has a GF Score™ of 50/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does OncoTherapy Science's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, OncoTherapy Science ranks #63 out of 638 companies for Days Inventory. This places OncoTherapy Science in the top 10% of its industry — outperforming the majority of peers. The industry median Days Inventory is 183.20. OncoTherapy Science's value of 35.93 is 80.4% below this benchmark. Historically, OncoTherapy Science's own Days Inventory has ranged from 25.04 to 55.20 over the past decade. While the company's 10-year median is 38.49 vs. the industry median of 183.20, OncoTherapy Science has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OncoTherapy Science's current Days Inventory of 35.93 is 80.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on OncoTherapy Science and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OncoTherapy Science's current Days Inventory is 35.93, which is near median its own 10-year median of 38.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoTherapy Science stock overvalued right now?
Based on GuruFocus' analysis, OncoTherapy Science (TSE:4564) is currently considered Modestly Overvalued. The stock's GF Value™ is 円16.92, compared to a current price of 円20.00 — trading 18.2% above its estimated fair value. The current Days Inventory is 35.93, which is near median its 10-year median of 38.49 and 80.4% below the Biotechnology industry median of 183.20. OncoTherapy Science's overall GF Score™ is 50/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For OncoTherapy Science (TSE:4564), the current Days Inventory is 35.93 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OncoTherapy Science (TSE:4564) Overvalued in 2026?
Based on GuruFocus' analysis, OncoTherapy Science stock appears to be overvalued.
The current stock price of 円20.00 is trading 18.2% above its estimated GF Value™ of 円16.92.
GuruFocus considers OncoTherapy Science to be Modestly Overvalued.
Key valuation signals for TSE:4564:
Days Inventory: 35.93 (near median its 10-year median of 38.49)
GF Value™: 円16.92 vs. price of 円20.00 (18.2% above fair value)
Industry Position: 80.4% below the Biotechnology median (#63 of 638)
No single metric tells the full story. See the TSE:4564 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OncoTherapy Science Inc focuses on cancer-related cells and genes and develops cancer therapy products which include low molecular drugs, antibody drugs, cancer peptide vaccine, and diagnostic medicine in Japan.
50GF Score
Get the complete analysis for TSE:4564
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4564 has been successfully added to your 
